Rodney Altman's Email & Phone Number

💼 Past Experience

Background:Rodney Altman is a health care industry PE and venture capital investor. He has also worked as an emergency physician at Stanford and Kaiser Permanente.Rodney Altman'sEducation:He earned his B.S. degree in Health Science from the University of California, Berkeley in 1984.Rodney Altman's Career experiences:Healthcare PE & Venture Capital Investor, Part-Time Emergency Physician at Stanford and Kaiser PermanenteIndustry of Venture Capital & Private Equityfrom March 2005 to March 2006, Rodney Altman as a Managing Director and Founder at Aphelion Capital from March 2006 to March 2006. Senior Partner at CMEA Capital from March 2006 to June 2011.He then worked as an emergency physician at Stanford from 1984-2006 and then at Kaiser Permanente from 2006-2011.

🎓 Education

Rodney Altman holds a doctorate in Medicine from the University of Chicago. He has also completed an Emergency Medicine Residency at the University of Illinois. Altman has experience working in the field of emergency medicine and has already served as an assistant medical officer in a hospitalized setting. Altman has been an active member of the scientific community and has published multiple papers in PubMed and many other journals. Altman is also a clinical professor at Rush University Medical Center and a member of the editorial board for the journal, Annals of Emergency Medicine.

💡 Technical & Interpersonal Skills

Rodney Altman is a HealthcarePE and Venture Capital Investor in the Industry of Venture Capital and Private Equity. Altman is also currently a Managing Director and Founder at Aphelion Capital from March 2005 to March 2006. Altman was also a Senior Partner at CMEA Capital from March 2006 to June 2011. Altman has been involved in the venture capital, private equity, and healthcare industries for over 20 years.Altman has invested in over a dozen roofless technology companies that have raised over $1 billion in venture capital. Altman's notable investment successes include Aphelion Capital's purchase of roofless technology company, ClimateTrace, for $164 million, ClimateTrace's sale to